LEXINGTON, Mass.--(BUSINESS WIRE)--Synta Pharmaceuticals Corp. (NASDAQ: SNTA), a biopharmaceutical company focused on discovering, developing, and commercializing small molecule drugs to treat severe medical conditions, today announced that the Company will be presenting at the Third Annual JMP Securities Healthcare Focus Conference on Tuesday, October 7, 2008 at 11:00 a.m. (ET) at the Le Parker Meridien Hotel in New York.
